Products for Research Use Only
RegisterLogin

Glecirasib

CAT: 0013-GTR19219505-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19219505-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Glecirasib (JAB-21822) is an oral KRAS G12C inhibitor that selectively targets and inactivates the mutant protein, blocking downstream oncogenic signaling. Preclinical studies in animal models demonstrate its antitumor efficacy and favorable safety profile, supporting its investigation in cancers driven by this mutation.
CAS Number
2657613-87-9
Product Name Alternative
KRAS G12C inhibitor 36, JAB21822, JAB-21822, JAB-21000, JAB21000
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
99.70% (May vary between batches)
Smiles
N#CC=1C (=O) N (C=2N=C (C (Cl) =CC2C1N3CCN (C (=O) C=C) CC3) C=4C (F) =C (F) C (F) =C (F) C4N) C=5C (=NC=CC5C) C (C) C
Molecular Formula
C31H26ClF4N7O2
Molecular Weight
640.03
Storage Conditions
-20°C
Notes
For research use only.

Alternative Products

CatalogName
MBS5820314Glecirasib
A24226-1Glecirasib (JAB-21822) 1mg
A24226-10Glecirasib (JAB-21822) 10mg
A24226-5Glecirasib (JAB-21822) 5mg
A24226-50Glecirasib (JAB-21822) 50mg

Popular Products